Výsledky vyhľadávania - "Pharmacoepidemiology methods"

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence

Autori: Rohini K. Hernandez Cathy W. Critchlow Nancy Dreyer a ďalší

Zdroj: Clin Pharmacol Ther
Hernandez, R K, Critchlow, C W, Dreyer, N, Lash, T L, Reynolds, R F, Sørensen, H T, Lange, J L, Gatto, N M, Sobel, R E, Lai, E C-C, Schoonen, M, Brown, J S, Christian, J B, Brookhart, M A & Bradbury, B D 2025, 'Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making : The Era of Real-World Evidence', Clinical Pharmacology and Therapeutics, vol. 117, no. 4, pp. 927-937. https://doi.org/10.1002/cpt.3563

Predmety: Technology Assessment, Biomedical, Evidence-Based Medicine, Research Design, Pharmacoepidemiology, Decision Making, Pharmacoepidemiology/methods, Evidence-Based Medicine/methods, Humans, Review, Delivery of Health Care

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39807817
https://pure.au.dk/portal/en/publications/2faea146-a0ae-4f70-b181-41b6f6ef3c04
http://www.scopus.com/inward/record.url?scp=85214705002&partnerID=8YFLogxK
https://doi.org/10.1002/cpt.3563

Revisión de alcance para la identificación y caracterización de autores, grupos de investigación y bases datos de uso secundario en el área de la Farmacoepidemiología en Colombia, Ecuador y Chile

Autori: Durán, Carlos E. orcid:0000-0003-1853- Mena Ayala, María Belén a ďalší

Predmety: Pharmacoepidemiology/education, Pharmacoepidemiology, Pharmacoepidemiology/methods

Relation: https://zenodo.org/communities/cefarmacoepidemiologiaypoliticaspublicas/; https://zenodo.org/records/15603330; oai:zenodo.org:15603330; https://doi.org/10.5281/zenodo.15603330

Dostupnosť: https://doi.org/10.5281/zenodo.15603330
https://zenodo.org/records/15603330

Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research

Autori: Shirley V Wang Anton Pottegård

Zdroj: Am J Epidemiol

Predmety: transparency, pharmacoepidemiology, Outcome Assessment, Health Care/standards, Practice of Epidemiology, Pharmacoepidemiology, Reproducibility of Results, Checklist, 03 medical and health sciences, 0302 clinical medicine, Research Design, open science, Outcome Assessment, Health Care, Pharmacoepidemiology/methods, Humans, real-world evidence, reproducibility, Research Design/standards

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38794897
https://portal.findresearcher.sdu.dk/da/publications/dd7cd1e8-b40a-4cfa-971b-ca8b5e4609a7
https://doi.org/10.1093/aje/kwae087

Use of Point‐in‐Time or Window Approach in the Case‐Crossover Design, Implications for Pharmacoepidemiologic Research Using Registries

Autori: Jesper Hallas Malcolm Maclure

Zdroj: Pharmacoepidemiology and Drug Safety. 33

Predmety: Cross-Over Studies, Time Factors, Research Design, Pharmacoepidemiology, Pharmacoepidemiology/methods, Humans, Registries

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38887901

Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research: Explore, Tailor, Implement, and Evaluate (ETIE)-A Framework of Diversity and Fairness in Pharmacoepidemiologic Research

Autori: Enriqueta Vallejo‐Yagüe Sieta T. de Vries Daniel La Parra‐Casado a ďalší

Zdroj: Pharmacoepidemiology and drug safety, vol. 34, no. 7, pp. e70175

Predmety: Europe, inclusion, pharmacoepidemiology, Health Equity, Humans, Pharmacoepidemiology/methods, Pharmacoepidemiology/standards, Cultural Diversity, diversity, fairness, health equity

Popis súboru: application/pdf

Prístupová URL adresa: https://pure.amsterdamumc.nl/en/publications/ccdb6e39-33ba-4049-abb3-e1988acfc758
https://doi.org/10.1002/pds.70175
https://serval.unil.ch/notice/serval:BIB_EAA46E5C4D16
https://serval.unil.ch/resource/serval:BIB_EAA46E5C4D16.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EAA46E5C4D162

Incidence in pharmacoepidemiology—Basic definitions and types of misclassification

Autori: Mikael Hoffmann Henrik Støvring

Zdroj: Basic Clin Pharmacol Toxicol

Predmety: Male, pharmacoepidemiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, misclassification, Incidence, Pharmacoepidemiology, Infant, Original Articles, incidence, run-in, statins, 3. Good health, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Kardiologi och kardiovaskulära sjukdomar, Predictive Value of Tests, Pharmacoepidemiology/methods, Humans, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Disease

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35357769
https://portal.findresearcher.sdu.dk/da/publications/e3c4c330-d59e-4254-abab-b684068b4e20
https://doi.org/10.1111/bcpt.13727
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-184534

A Two-Step Framework for Validating Causal Effect Estimates

Autori: Shen, Lingjie Visser, Erik van Erning, Felice a ďalší

Zdroj: Shen, L, Visser, E, van Erning, F, Geleijnse, G & Kaptein, M 2024, 'A Two-Step Framework for Validating Causal Effect Estimates', Pharmacoepidemiology and Drug Safety, vol. 33, no. 9, e5873. https://doi.org/10.1002/pds.5873

Predmety: causal estimates, sampling mechanism, treatment assignment mechanism, validation, Reproducibility of Results, Data Interpretation, Statistical, Humans, Randomized Controlled Trials as Topic/methods, Bias, Confounding Factors, Epidemiologic, Pharmacoepidemiology/methods, Observational Studies as Topic/methods, Registries/statistics & numerical data, Computer Simulation, Selection Bias, Causality, Research Design

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39252380; info:eu-repo/semantics/altIdentifier/pissn/1053-8569; info:eu-repo/semantics/altIdentifier/eissn/1099-1557

Dostupnosť: https://research.tue.nl/en/publications/ee5ba8be-3a52-4643-9619-c4233bb281e2
https://doi.org/10.1002/pds.5873
https://pure.tue.nl/ws/files/352334559/Pharmacoepidemiology_and_Drug_-_2024_-_Shen_-_A_Two_Step_Framework_for_Validating_Causal_Effect_Estimates.pdf
https://www.scopus.com/pages/publications/85203426694

Considerations for Pharmacoepidemiological Studies of Drug–Cancer Associations

Autori: Til Stürmer Jesper Hallas Anton Pottegård a ďalší

Zdroj: Pottegard, A, Friis, S, Stürmer, T, Hallas, J & Bahmanyar, S 2018, ' Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 5, pp. 451-459 . https://doi.org/10.1111/bcpt.12946
Pottegård, A, Friis, S, Stürmer, T, Hallas, J & Bahmanyar, S 2018, ' Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 5, pp. 451-459 . https://doi.org/10.1111/bcpt.12946

Predmety: Time Factors, Drug-Related Side Effects and Adverse Reactions, Pharmacoepidemiology, Confounding Factors, Epidemiologic, Prognosis, Confounding Factors (Epidemiology), Risk Assessment, 3. Good health, Observational Studies as Topic, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Epidemiologic Research Design, Neoplasms, Neoplasms/chemically induced, Pharmacoepidemiology/methods, Humans, Drug-Related Side Effects and Adverse Reactions/diagnosis

Popis súboru: application/pdf

Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.12946
https://pubmed.ncbi.nlm.nih.gov/29265740
https://www.ncbi.nlm.nih.gov/pubmed/29265740
https://portal.findresearcher.sdu.dk/da/publications/considerations-for-pharmacoepidemiological-studies-of-drug-cancer
https://europepmc.org/abstract/MED/29265740
https://onlinelibrary.wiley.com/doi/10.1111/bcpt.12946
https://pubmed.ncbi.nlm.nih.gov/29265740/
https://findresearcher.sdu.dk:8443/ws/files/142966384/Considerations_for_Pharmacoepidemiological_Studies_of_Drug_Cancer_Associations.pdf
https://curis.ku.dk/ws/files/209595853/Considerations_for_Pharmacoepidemiological_Studies_of_Drug_Cancer_Associations.pdf
https://portal.findresearcher.sdu.dk/da/publications/83090fa8-7f13-41b8-97bb-bbc5f9c4e87c
https://doi.org/10.1111/bcpt.12946
https://findresearcher.sdu.dk:8443/ws/files/142966384/Considerations_for_Pharmacoepidemiological_Studies_of_Drug_Cancer_Associations.pdf

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects

Autori: Kaleen N. Hayes Tara Gomes Mina Tadrous

Zdroj: Frontiers in Pharmacology, Vol 12 (2021)

Predmety: antipsychotic agents, dementia, dose-response relationship, drug, drug prescriptions, pharmacoepidemiology/methods, Therapeutics. Pharmacology, RM1-950

Popis súboru: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.709349/full; https://doaj.org/toc/1663-9812

Prístupová URL adresa: https://doaj.org/article/8f29bd4811294e1d87eb44805f06ea13

Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.

Autori: Daubner, Johanna Arshaad, Muhammad Imran Henseler, Christina a ďalší

Zdroj: Neural plasticity 2021, 1 - 27 (2021). doi:10.1155/2021/8823383

Predmety: info:eu-repo/classification/ddc/610, Affect: drug effects, Affect: physiology, Central Nervous System Stimulants: chemical synthesis, Central Nervous System Stimulants: classification, Central Nervous System Stimulants: pharmacology, Drug Development: methods, Drug Development: trends, Ethics, Forecasting, Humans, Motivation: drug effects, Motivation: physiology, Nootropic Agents: chemical synthesis, Nootropic Agents: classification, Nootropic Agents: pharmacology, Pharmacoepidemiology: methods, Pharmacoepidemiology: trends

Geografické téma: DE

Relation: info:eu-repo/semantics/altIdentifier/issn/0792-8483; info:eu-repo/semantics/altIdentifier/issn/1687-5443; info:eu-repo/semantics/altIdentifier/issn/1352-237X; info:eu-repo/semantics/altIdentifier/issn/2090-5904; info:eu-repo/semantics/altIdentifier/pmid/pmid:33519929; https://pub.dzne.de/record/154585

Dostupnosť: https://pub.dzne.de/record/154585
https://pub.dzne.de/search?p=id:%22DZNE-2021-00263%22

Public Health and Epidemiology Informatics

Autori: Flahault, Antoine Bar-Hen, A Paragios, N

Zdroj: Yearbook of Medical Informatics, Vol. 25, No 1 (2016) pp. 240-246

Predmety: 0301 basic medicine, 0303 health sciences, Pharmacoepidemiology, Datasets as Topic, 3. Good health, Population Surveillance/methods, 03 medical and health sciences, Artificial Intelligence, Population Surveillance, Pharmacoepidemiology/methods, Data Mining, Humans, Public Health, Epidemiologic Methods, ddc:613

Popis súboru: application/pdf

Prístupová URL adresa: http://www.thieme-connect.de/products/ejournals/pdf/10.15265/IY-2016-021.pdf
https://pubmed.ncbi.nlm.nih.gov/27830257
https://www.thieme-connect.de/products/ejournals/pdf/10.15265/IY-2016-021.pdf
https://www.thieme-connect.com/products/ejournals/abstract/10.15265/IY-2016-021
https://www.thieme-connect.com/products/ejournals/pdf/10.15265/IY-2016-021.pdf
https://archive-ouverte.unige.ch/unige:98748
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171550
https://archive-ouverte.unige.ch/unige:98748/ATTACHMENT01
https://archive-ouverte.unige.ch/unige:98748

Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics

Autori: Kaguelidou, Florentia Durrieu, Geneviève Clavenna, Antonio a ďalší

Prispievatelia: Kaguelidou, Florentia Durrieu, Geneviève Clavenna, Antonio a ďalší

Zdroj: Thérapie ; https://hal.science/hal-03486759 ; Thérapie, 2019, 74 (2), pp.315 - 324. ⟨10.1016/j.therap.2018.09.077⟩

Predmety: Pharmacoepidemiology, Pediatrics, Drug development, Challenges, MESH: Child, MESH: Drug Development / legislation & jurisprudence, MESH: Pharmacovigilance, MESH: United States, MESH: Drug Development / methods, MESH: Drug and Narcotic Control, MESH: Drug-Related Side Effects and Adverse Reactions / epidemiology, MESH: Drug-Related Side Effects and Adverse Reactions / prevention & control, MESH: Europe, MESH: Humans, MESH: Pediatrics, MESH: Pharmacoepidemiology / methods, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/30773345; PUBMED: 30773345

Dostupnosť: https://hal.science/hal-03486759
https://hal.science/hal-03486759v1/document
https://hal.science/hal-03486759v1/file/S0040595719300253.pdf
https://doi.org/10.1016/j.therap.2018.09.077

Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study: a Danish nationwide cohort study

Autori: Anton Pottegård Per Damkier Jette Østergaard Rathe a ďalší

Zdroj: Hellfritzsch, M, Østergaard Rathe, J, Stage, T B, Thirstrup, S, Grove, E L, Damkier, P & Pottegård, A 2016, ' Generic switching of warfarin and risk of excessive anticoagulation : a Danish nationwide cohort study ', Pharmacoepidemiology and Drug Safety, vol. 25, no. 3, pp. 336-343 . https://doi.org/10.1002/pds.3942
Hellfritzsch, M, Rathe, J, Stage, T B, Thirstrup, S, Grove, E L, Damkier, P & Pottegård, A 2015, 'Generic switching of warfarin and risk of excessive anticoagulation : a Danish nationwide cohort study', Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.3942

Predmety: Anticoagulants/administration & dosage, Denmark, Pharmacoepidemiology, Drugs, Anticoagulants, Hemorrhage, Drugs, Generic/administration & dosage, Adverse Drug Reaction Reporting Systems/statistics & numerical data, Denmark/epidemiology, 3. Good health, Cohort Studies, Warfarin/administration & dosage, 03 medical and health sciences, 0302 clinical medicine, Generic/administration & dosage, Journal Article, Hemorrhage/blood, Pharmacoepidemiology/methods, Adverse Drug Reaction Reporting Systems, Drugs, Generic, Humans, International Normalized Ratio, Warfarin

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/26696392
https://portal.findresearcher.sdu.dk/da/publications/generic-switching-of-warfarin-and-risk-of-excessive-anticoagulati
http://europepmc.org/abstract/MED/26696392
https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.3942
http://www.ncbi.nlm.nih.gov/pubmed/26696392
https://www.ncbi.nlm.nih.gov/pubmed/26696392
https://portal.findresearcher.sdu.dk/da/publications/8a41dac1-604b-4390-9e2b-20599c3f394a
https://portal.findresearcher.sdu.dk/da/publications/8a41dac1-604b-4390-9e2b-20599c3f394a
https://doi.org/10.1002/pds.3942

Design and methods of a postmarketing pharmacoepidemiology study assessing long‐term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis

Autori: Xue, Fei Ma, Haijun Stehman-Breen, Catherine a ďalší

Zdroj: Pharmacoepidemiol Drug Saf
Xue, F, Ma, H, Stehman-Breen, C, Haller, C, Katz, L, Wagman, R B, Critchlow, C W, Delzell, E, Curtis, J R, Dore, D, Wang, F, Sorensen, H T, Pedersen, L & Ehrenstein, V 2013, 'Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia ® (denosumab) for the treatment of postmenopausal osteoporosis', Pharmacoepidemiology and Drug Safety, vol. 22, no. 10, pp. 1107-1114. https://doi.org/10.1002/pds.3477

Predmety: 0301 basic medicine, Denmark, Antibodies, Monoclonal, Humanized, Database, Cohort Studies, Pharmacovigilance, 03 medical and health sciences, Postmarketing drug safety, Postmenopausal osteoporosis, 0302 clinical medicine, Risk Factors, Pharmacoepidemiology methods, Original Reports, Humans, Prolia (denosumab), Osteoporosis, Postmenopausal, Aged, Bone Density Conservation Agents, Pharmacoepidemiology, Middle Aged, United States, 3. Good health, Treatment Outcome, Female, Denosumab, Safety, Follow-Up Studies

Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.3477
https://pubmed.ncbi.nlm.nih.gov/23857864
http://europepmc.org/articles/PMC4230463
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3477
https://pubmed.ncbi.nlm.nih.gov/23857864/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230463/
https://onlinelibrary.wiley.com/doi/full/10.1002/pds.3477
https://pure.au.dk/portal/en/publications/cb88b6bb-d279-4629-98f5-311a98549823
http://www.scopus.com/inward/record.url?scp=84884988518&partnerID=8YFLogxK
https://doi.org/10.1002/pds.3477

Use of multiple international healthcare databases for the detection of rare drug‐associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins

Autori: Luis A. García Rodríguez Ron M. C. Herings Saga Johansson

Zdroj: Garcia Rodriguez, L A, Herings, R & Johansson, S 2010, 'Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins', Pharmacoepidemiology and Drug Safety, vol. 19, no. 12, pp. 1218-1224. https://doi.org/10.1002/pds.2032

Predmety: Male, Sulfonamides, Databases, Factual, Acute Kidney Injury/chemically induced/epidemiology Chemical and Drug Induced Liver Injury/epidemiology/etiology Databases, International Cooperation, Pharmacoepidemiology, Acute Kidney Injury, Middle Aged, Factual Female Fluorobenzenes/*adverse effects Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects International Cooperation Male Middle Aged Muscular Diseases/chemically induced/epidemiology Pharmacoepidemiology/*methods Pyrimidines/*adverse effects Rosuvastatin Calcium Sulfonamides/*adverse effects, 3. Good health, Fluorobenzenes, 03 medical and health sciences, Pyrimidines, 0302 clinical medicine, Muscular Diseases, Humans, Female, Chemical and Drug Induced Liver Injury, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rosuvastatin Calcium

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/20922707
http://www.ncbi.nlm.nih.gov/pubmed/20922707
https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/pds.2032
https://repub.eur.nl/pub/21955/
https://onlinelibrary.wiley.com/doi/10.1002/pds.2032
https://pubmed.ncbi.nlm.nih.gov/20922707/
https://research.vumc.nl/en/publications/8ef19f1a-3be1-46ce-9cbd-03bc4f58b559

Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.

Autori: Feltelius, N Fored, C M Blomqvist, P a ďalší

Zdroj: Ann Rheum Dis. 64(2):246-52

Predmety: Adult, Aged, Antirheumatic Agents/*adverse effects/therapeutic use, Arthritis, Rheumatoid/*drug therapy, Female, Humans, Immunoglobulin G/*adverse effects/therapeutic use, Male, Middle Aged, National Health Programs/organization & administration, Pharmacoepidemiology/methods, Product Surveillance, Postmarketing/*methods, Receptors, Tumor Necrosis Factor/therapeutic use, Severity of Illness Index, Sweden, Treatment Outcome

Popis súboru: print

Prístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-14543

Socio-economic inequalities in first-time use of antidepressants: a population-based study: a population-based study

Autori: Hansen, D G Søndergaard, J Vach, W a ďalší

Zdroj: Hansen, D G, Sondergaard, J, Vach, W & Ukendt, M F 2004, ' Socio-economic inequalities in first-time use of antidepressants: a population-based study. ', European Journal of Clinical Pharmacology, vol. 60, no. 1, pp. 51-55 .
Hansen, D G, Søndergaard, J, Vach, W, Gram, L F, Rosholm, J-U, Mortensen, P B & Kragstrup, J 2004, ' Socioeconomic inequalities in first-time use of antidepressants : a population-based study ', European Journal of Clinical Pharmacology, vol. 60, pp. 51-55 .
Hansen, D G, Vach, W, Mortensen, P B, Rosholm, J U, Søndergaard, J, Gram, L F & Kragstrup, J 2004, 'Socio-economic inequalities in first-time use of antidepressants: a population-based study', European Journal of Clinical Pharmacology, vol. 60, pp. 51-55.
Hansen, D G, Søndergaard, J, Vach, W, Gram, L F, Rosholm, J U, Mortensen, P B & Kragstrup, J 2004, 'Socio-economic inequalities in first-time use of antidepressants: a population-based study', Eur. J. Clin. Pharmacol, vol. 66, no. 1, pp. 83-85.

Predmety: Adult, Male, Drug Prescriptions/statistics & numerical data, Monoamine Oxidase Inhibitors, Time Factors, Adolescent, Denmark, Mental Disorders, Pharmacoepidemiology, 1. No poverty, Middle Aged, Antidepressive Agents/therapeutic use, Drug Prescriptions, Antidepressive Agents, 3. Good health, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Socioeconomic Factors, Pharmacoepidemiology/methods, Monoamine Oxidase Inhibitors/therapeutic use, Humans, Female, 10. No inequality, Aged

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/14968270
https://www.ncbi.nlm.nih.gov/pubmed/14968270
https://core.ac.uk/display/50646267
https://portal.findresearcher.sdu.dk/da/publications/socio-economic-inequalities-in-first-time-use-of-antidepressants-
https://link.springer.com/article/10.1007%2Fs00228-003-0723-y
https://europepmc.org/article/MED/14968270
https://link.springer.com/article/10.1007/s00228-003-0723-y/fulltext.html
https://portal.findresearcher.sdu.dk/da/publications/d30fbc80-e9c3-11db-821c-000ea68e967b
https://doi.org/10.1007/s00228-003-0723-y
https://portal.findresearcher.sdu.dk/da/publications/887302d0-fc7a-11db-9e98-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/887302d0-fc7a-11db-9e98-000ea68e967b
https://doi.org/10.1007/s00228-003-0723-y
https://portal.findresearcher.sdu.dk/da/publications/d30fbc80-e9c3-11db-821c-000ea68e967b
https://pure.au.dk/portal/en/publications/8c1a6560-2c44-11db-bee9-02004c4f4f50
https://pure.au.dk/portal/en/publications/0c87a5c0-9846-11da-bee9-02004c4f4f50

Guidelines for good pharmacoepidemiology practice (GPP)

Zdroj: Public Policy Committee, International Society of Pharmacoepidemiology 2016, ' Guidelines for good pharmacoepidemiology practice (GPP) ', Pharmacoepidemiology and Drug Safety, vol. 25, no. 1, pp. 2-10 . https://doi.org/10.1002/pds.3891

Predmety: Research Subjects, Data Collection, Data Interpretation, Statistical, Pharmacoepidemiology/methods, Information Storage and Retrieval, Epidemiologic Methods, Goals, Research Design/standards

Prístupová URL adresa: https://portal.findresearcher.sdu.dk/da/publications/0e6876ca-3a44-48f3-a5bd-9f2f22ed7d98

A normalization method for combination of laboratory test results from different electronic healthcare databases in a distributed research network

Autori: Yoon, D Schuemie, MJ Kim, JH a ďalší

Prispievatelia: Yoon, D Schuemie, MJ Kim, JH a ďalší

Predmety: Clinical Laboratory Information Systems/standards, Clinical Laboratory Information Systems/trends, Comparative Effectiveness Research/methods, Computer Simulation, Databases, Factual/standards, Factual/trends, Electronic Health Records/standards, Electronic Health Records/trends, Laboratories, Hospital/standards, Pharmacoepidemiology/methods, Republic of Korea, Retrospective Studies, Software, envir, demo

Relation: http://repository.ajou.ac.kr/handle/201003/14736

Dostupnosť: http://repository.ajou.ac.kr/handle/201003/14736

A normalization method for combination of laboratory test results from different electronic healthcare databases in a distributed research network

Autori: Yoon D||Schuemie MJ||Kim a ďalší

Prispievatelia: Yoon D||Schuemie MJ||Kim a ďalší

Predmety: Clinical Laboratory Information Systems/standards*||Clinical Laboratory Information Systems/trends||Comparative Effectiveness Research/methods*||Computer Simulation*||Databases, Factual/standards*||Databases, Factual/trends||Electronic Health Records/standards*||Electronic Health Records/trends||Laboratories, Hospital/standards||Pharmacoepidemiology/methods*||Republic of Korea||Retrospective Studies||Software, envir, demo

Relation: http://repository.ajou.ac.kr/handle/201003/14582

Dostupnosť: http://repository.ajou.ac.kr/handle/201003/14582